A liquid biopsy-RNAseq method for monitoring the expression of genes involved in drug disposition: Proof-of-concept application to cholestatic liver disease.

Dahal A, Sierra T, Hayes CM, Assis DN, Rostami-Hodjegan A, Ghonem NS, Achour B

Open source

DOI
10.1016/j.jpba.2025.117244
Published
2026 Feb 15
Container
Journal of pharmaceutical and biomedical analysis
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.jpba.2025.117244,
  title = {A liquid biopsy-RNAseq method for monitoring the expression of genes involved in drug disposition: Proof-of-concept application to cholestatic liver disease.},
  author = {Dahal A and Sierra T and Hayes CM and Assis DN and Rostami-Hodjegan A and Ghonem NS and Achour B},
  year = {2026},
  journal = {Journal of pharmaceutical and biomedical analysis},
  doi = {10.1016/j.jpba.2025.117244},
  url = {https://doi.org/10.1016/j.jpba.2025.117244}
}

RIS

TY  - JOUR
TI  - A liquid biopsy-RNAseq method for monitoring the expression of genes involved in drug disposition: Proof-of-concept application to cholestatic liver disease.
AU  - Dahal A
AU  - Sierra T
AU  - Hayes CM
AU  - Assis DN
AU  - Rostami-Hodjegan A
AU  - Ghonem NS
AU  - Achour B
PY  - 2026
JO  - Journal of pharmaceutical and biomedical analysis
DO  - 10.1016/j.jpba.2025.117244
UR  - https://doi.org/10.1016/j.jpba.2025.117244
ER  - 

APA

A, D., T, S., CM, H., DN, A., A, R., NS, G., & B, A. (2026). A liquid biopsy-RNAseq method for monitoring the expression of genes involved in drug disposition: Proof-of-concept application to cholestatic liver disease.. Journal of pharmaceutical and biomedical analysis. https://doi.org/10.1016/j.jpba.2025.117244

Source records